Hepatitis B infection is highly endemic in Uganda: Findings from a national serosurvey

African Health Sciences

Volumn 9, Issue 2, 2009, Pages 98-108

  Bwogi, Josephine ^a   Braka, Fiona ^b   Makumbi, Issa ^c   Mishra, Vinod ^d   Bakamutumaho, Barnabas ^a   Nanyunja, Miriam ^b   Opio, Alex ^c   Downing, Robert ^e   Biryahwaho, Benon ^a   Lewis, Rosamund F ^b  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MINISTRY OF HEALTH   (Uganda)

^d Demographic and Health Research Division   (United States)

^e CDC Uganda   (Uganda)

Author keywords

Circumcision; Coinfection; HBcAb; HBsAg; Hepatitis B; HIV; Immunization; Survey; Uganda; Vaccine

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B CORE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CIRCUMCISION; DEMOGRAPHY; EDUCATIONAL STATUS; ENDEMIC DISEASE; ETHNICITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; OCCUPATION; QUESTIONNAIRE; RELIGION; RISK FACTOR; RURAL AREA; SEROPREVALENCE; SEX RATIO; UGANDA; BLOOD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; HEALTH SURVEY; IMMUNOLOGY; MIDDLE AGED; PREVALENCE; SOCIOECONOMICS; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; UGANDA; YOUNG ADULT;

EID: 68949198024     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kane MA. Global status of hepatitis B immunization. Lancet 1996; 348:696.
2. Kao JH CD. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.
3. World Health Organization. Department of Communicable Diseases Surveillance and Response. Hepatitis B. WHO/CDS/CSR/LYO/2002.2. www. w h o. i n t / c s r / d i s e a s e / h e p a t i t i s / HepatitisB-whocdscsrlyo2002-2. pdf. accessed 29 June 2007.
4. World Health Organization. Hepatitis B Vaccines. WHO position paper. WER 2004; 28(79):255-263. www.who.int/wer/2004/en/wer7928.pdf, accessed 29 June 2007.
5. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization; an economic analysis of current recommendations. JAMA 1995;264:1201-1208.
6. World Health Organization. Hepatitis B vaccine. Making Global progress. WHO, October 1996. www.who.int/ vaccines-documents/DoxNews/updates/updat31e.pdf, Accessed 27 June 2007.
7. Watson-Williams EJ, Kataaha P. Revival of Ugandan blood transfusion system 1989. An example of international cooperation. Transfus Sci 1990;11(2): 179-184.
8. De Lalla F, Rizzardini G, Rinaldi E, Santoro D, Zelli PL, Vega G. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas. Trans R Soc Trop Med Hyg 1990:84:144-147.
9. Goodgame RW. Aids in Uganda-clinical and social features. N Engl J Med 1990;323:383-389.
10. Pido B, Kagimu M. Prevalence of Hepatitis B Virus (HBV) infection among Makerere University medical students. Afr Health Sci 2005;5:93-98.
11. Ziraba AK. Prevalence and factors associated with hepatitis B infection among health workers in Mulago Hospital [dissertation]. Makerere University, Kampala, Uganda. 2003.
12. Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF. Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection. Vaccine 2006; 24: 6930-6937.
13. Nakwagala FN, Kagimu MM. Hepatitis B and HIV infections among patients in Mulago Hospital. East Afr Med J 2002;79(2); 68-72.
14. Grob P, Jilg W, Bohnhak H, et al. Serological pattern "HBcAb Alone": Report on a workshop. J Med Virol 2000; 62: 450-455.
15. Aylward B, Kane M, McNair-Scott R, Hu DJ. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections. Int J Epidemiol.1995;24:446-452.
16. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999;77(10):789-800.
17. Ekwueme DU, Weniger BG, Chen RT. Model based estimates of risk of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull World Health Organ 2002;80(11):859-870.
18. Hudson CP, Hennis AJ, Kataaha P, et al. Risk factors for the spread of AIDS in rural Africa: evidence from a comparative seroepidemiological survey of AIDS, hepatitis B and syphilis in southwestern Uganda. AIDS 1988; 2:255-260.
19. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13 Suppl 1: S47-49.
20. World Health Organization: Uganda reported immunization coverage. [www.who.int/immunization-monitoring/en/ g l o b a l s u m m a r y / t i m e s e r i e s / tscoveragebycountry.cfm?country=Uganda, accessed 16 June 2007].
21. Ministry of Health [Uganda] and ORC Macro. Uganda HIV/ AIDS Sero-behavioural Survey 2004-2005. Calverton, Maryland, USA: Ministry of Health and ORC Macro, 2006:114-116
22. Mishra V, Musinguzi J, Cross A, Opio A, Hong R, Kirungi W, Kafuko J, Mermin J. The 2004-05 Uganda HIV/AIDS Sero-Behavioural Survey: methods and impact of non-response bias. Uganda Ministry of Health Working Paper No. 1. Kampala, Uganda: Ministry of Health.
23. Uganda Bureau of Statistics. Uganda 2002 Population and Housing Census Main Report. www.ubos.org/onlinefiles/ uploads/ubos/pdf%20documents, Accessed 1 May 2008].
24. Kiire CF and the African Regional Study Group. Hepatitis B infection in sub-Saharan Africa. Vaccine 1990; 8 (Suppl.1);107-112.
25. Uganda Bureau of Statistics (UBOS) and ORC Macro.2001.Uganda Demographic and Health Survey 2000-2001. Calverton, Maryland, USA: UBOS and ORC Macro.
26. Ssewanyana S, Nabyonga OJ, Kasirye I, Lawson D. Demand for health care services in Uganda. Implications for poverty reduction. Economic Policy Research Center (EPRC), Kampala, Uganda. March 2004. www.eprc.or.ug/pdf-files/ researchseries/series40.pdf. Accessed 12 December 2007.
27. Martinson FEA, Weigle KA, Royce RA et al. Risk factors for horizontal transmission of hepatitis B in a rural district in Ghana. Am J Epidemiol 1998; 147:478-87.
28. Burnett RJ, Francois G, Kew MC, et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub Saharan Africa: a call for further investigation. Liver International 2005; 25:201-213.
29. Tien PC, Kovacs A, Bacchetti P, et al. Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B Virus infection in the Women's Interagency HIV Study. Clin Inf Dis 2004; 39;1363-1370.
30. Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007 Mar 13;7(1):16.
31. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007 Feb 24;369:657-666.
32. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369:643-656.
33. Jacobs B, Mayaud P, Changalucha J, et al. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm dis 1997;24:121-126.
34. Hladik W, Kataaha P, Mermin J, et al. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Tropical Medicine and International Health 2006; 6:1-4.
35. Eller LA, Eller MA, Ouma B, et al. Reference intervals in Health Adults Ugandan Blood donors and their inpact on Conducting International Vaccine Trails.PLos ONE 2008: 3(12): e3919.doi:10.1371/journal.pone.0003919
36. Waite J, Gilson RJ, Weller IV, et al. Hepatitis B reactivation or reinfection associated with HIV-1 infection. AIDS 1988;2:443-448.
37. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses 8. Clin Infect Dis 1994; 18(3):339-347.
38. Vento S, Di Perri G, Luzzati R, et al. Clinical reactivation of hepatitis B in anti-HBs positive patients with AIDS. Lancet 1989;1(8633):332-333.
39. Mpahahlele MJ, Francois G, Kew MC, Van Damme P, Hoosen AA, Meheus A. Epidemiology and Control of hepatitis B: Implications for eastern and southern Africa. S. Afr J Epidemiol Infec 2002; 17(1,2): 12-17.
40. Gunson RN, Shouval D, Roggendorf M, et al. Hepatitis B Virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. Journal of Clinical Virology 2003; 27:213-230.